Related Experiment Videos
Protective effect of ethanol against epinephrine-induced myocardial necrosis in rats
Insights
Ethanol protects rat hearts from epinephrine-induced myocardial necrosis. This protective effect, observed with varying ethanol doses, was not attributed to reduced fatty acids, cardiac contractility, or other specific mechanisms.
Area of Science:
- Cardiology
- Pharmacology
- Toxicology
Background:
- Epinephrine administration can induce myocardial necrosis in rats.
- Assessing cardiac injury severity is crucial for understanding cardiotoxicity.
- Investigating protective agents against cardiac damage is a significant research area.
Purpose of the Study:
- To evaluate the protective effects of ethanol against epinephrine-induced myocardial necrosis in rats.
- To explore potential mechanisms underlying ethanol's cardioprotective action.
Main Methods:
- Myocardial necrosis was induced in rats using a single subcutaneous dose of epinephrine.
- Cardiac injury was assessed via visual inspection, enzyme release (LDH, CPK, GOT, HBDH), and technetium-99m-methylene diphosphonate uptake.
- Ethanol was administered at various doses prior to epinephrine challenge.
Main Results:
- Ethanol demonstrated a dose-dependent protective effect against epinephrine-induced cardiac injury.
- The protective action of ethanol was observed when administered 15 minutes or two hours before epinephrine.
- Mechanisms investigated, including reduced free fatty acids, cardiac contractility, caloric effect, platelet aggregation interference, and analgesia, did not explain ethanol's protection.
Conclusions:
- Ethanol provides significant protection against epinephrine-induced myocardial necrosis in a rat model.
- The cardioprotective mechanism of ethanol in this context remains to be elucidated, as common hypotheses were ruled out.
Abstract:
Myocardial necrosis was produced in rats by the subcutaneous injection of a single dose of epinephrine (3 mg base/kg). The severity of the cardiac injury produced was assessed by visual inspection, determination of the release of LDH, CPK, GOT, and HBDH from isolated perfused hearts, and measurement of cardiac uptake of technetium-99m-methylene diphosphonate in vivo. Ethanol, given in doses of 0.5 to 6.0 gm/kg 15 minutes or two hours prior to epinephrine administration protected the hearts against the epinephrine-produced injury, the degree of protection increasing with dose. Investigations of possible mechanisms of action of ethanol indicated that the protective action of the latter does not appear to be due to a lowering of plasma free fatty acid levels, a reduction of cardiac contractility, a non-specific caloric effect, an interference with epinephrine-induced platelet aggregation, or ethanol-induced analgesia.